Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

Basal cell carcinoma mostly starts from cells in the upper skin layers, not hair follicle stem cells.

Most people with basal cell carcinoma on their head or neck were 60-70 years old, and it often came back even after being fully removed, especially in certain areas and types.

Basal cell carcinomas have much higher levels of Vitamin D3 receptors compared to healthy skin.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

Reflectance confocal microscopy reliably identifies skin cancer features like horizontal skin tissue sections.

The patient was diagnosed with oral lichen sclerosus and needs long-term monitoring.

Understanding molecular processes in skin development is key to creating targeted treatments for skin disorders.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

A woman with a new PTCH gene mutation has both Gorlin syndrome and severe hair loss.

Some skin tumors from hair follicles and glands can be linked to genetic syndromes and may be benign or malignant.

A 90-year-old woman's hand lesion was a rare, aggressive skin cancer treated successfully with surgery.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Long-standing benign tumors can become cancerous, especially in people with weakened immune systems.

SOX9 helps determine stem cell roles by interacting with DNA and proteins that control gene activity.

Different soft tissue fillers can cause various skin reactions; biodegradable fillers are safer and non-biodegradable ones like silicone can lead to long-term problems.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Human skin can make serotonin and melatonin, which help protect and maintain it.

Apoptosis is crucial for healthy skin and treating skin diseases.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

GLI1 RNA CISH effectively identifies basal cell carcinoma but is less specific for benign follicular tumors.

A new skin cancer can develop where shingles once occurred.

A patient with Sézary syndrome showed improvement after treatment and the study suggested follicular mucinosis might indicate future lymphoma risk.

Human skin can make serotonin and melatonin.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

The issue concluded that various skin conditions have different effective treatments and factors influencing them.